GB1300486A - Compositions for the treatment of respiratory ailments in man - Google Patents

Compositions for the treatment of respiratory ailments in man

Info

Publication number
GB1300486A
GB1300486A GB5706570A GB5706570A GB1300486A GB 1300486 A GB1300486 A GB 1300486A GB 5706570 A GB5706570 A GB 5706570A GB 5706570 A GB5706570 A GB 5706570A GB 1300486 A GB1300486 A GB 1300486A
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
man
respiratory ailments
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5706570A
Inventor
Vincent Thomas William Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB5706570A priority Critical patent/GB1300486A/en
Publication of GB1300486A publication Critical patent/GB1300486A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1300486 Medicines for respiratory ailments V T W PORTER 31 Aug 1971 [1 Dec 1970] 57065/70 Heading A5B Compositions for the treatment of respiratory diseases such as bronchitis, asthma and emphysema comprise chlorpromazine hydrochloride and nitrazepam. Suitably, they may be in unit dosage form, e.g. a tablet, comprising 25-50 mg of chlorpromazine hydrochloride and 5-10 mg of nitrazepam.
GB5706570A 1970-12-01 1970-12-01 Compositions for the treatment of respiratory ailments in man Expired GB1300486A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5706570A GB1300486A (en) 1970-12-01 1970-12-01 Compositions for the treatment of respiratory ailments in man

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5706570A GB1300486A (en) 1970-12-01 1970-12-01 Compositions for the treatment of respiratory ailments in man

Publications (1)

Publication Number Publication Date
GB1300486A true GB1300486A (en) 1972-12-20

Family

ID=10478270

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5706570A Expired GB1300486A (en) 1970-12-01 1970-12-01 Compositions for the treatment of respiratory ailments in man

Country Status (1)

Country Link
GB (1) GB1300486A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316897A (en) 1980-09-10 1982-02-23 Hoffmann-La Roche Inc. Method of lowering serum prolactin
US4666907A (en) * 1983-10-05 1987-05-19 Merck Frosst Canada, Inc. Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors
US4845083A (en) * 1983-10-05 1989-07-04 Merck Frosst Canada, Inc. Method of inhibiting mammalian leukotriene biosynthesis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316897A (en) 1980-09-10 1982-02-23 Hoffmann-La Roche Inc. Method of lowering serum prolactin
US4666907A (en) * 1983-10-05 1987-05-19 Merck Frosst Canada, Inc. Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors
US4845083A (en) * 1983-10-05 1989-07-04 Merck Frosst Canada, Inc. Method of inhibiting mammalian leukotriene biosynthesis

Similar Documents

Publication Publication Date Title
IL38364A0 (en) 8-azapurin-6-one derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
IL36320A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL37984A0 (en) 2,4-diamino-5-benzylpyrimidine derivatives,their preparation and pharmaceutical compositions containing them
AU463957B2 (en) Piperazine derivatives, processes for their preparation and pharmaceutical compositions containing thesame
IL34713A (en) Anaesthetic pharmaceutical preparations containing 3alpha-hydroxy-5alpha-pregnane 11,20-dione
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
IL37280A (en) Adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA71951B (en) Dosage units for the administration of medicaments and the like
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
GB1202148A (en) Pharmaceutical compositions
CA944692A (en) Pharmaceutical composition and process for the preparation thereof
GB1118606A (en) Compositions for the treatment of haemorrhoids
IL37839A0 (en) Cinnoline derivatives,their preparation and pharmaceutical compositions containing them
IL37047A0 (en) Substituted amidines,their preparation and pharmaceutical compositions containing them
IL36127A (en) 6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha,17alpha-isopropylidenedioxy-pregna-1,4diene 21-esters,their preparation and pharmaceutical compositions containing them
IL36549A (en) Substituted imidazolines-(2),their preparation and pharmaceutical compositions containing them
GB1125924A (en) Organic bismuth derivative
GB1310171A (en) Pharmaceutical products for the treatment of migraine
IL35070A0 (en) Dibenzazepine derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL38199A0 (en) 2-acryloyl benzimidazoles,their preparation and pharmaceutical compositions containing them
IL36827A0 (en) Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
GB1174362A (en) Oral Medicants for Haemorrhoids.
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees